The DEXTER Robotic Surgical procedure System is designed to be straightforward to maneuver and use. Supply: Distalmotion
Robotic-assisted surgical procedure is coming to extra working rooms. Distalmotion SA in the present day stated it has efficiently closed its Collection G financing spherical with $150 million. The medical expertise firm stated it plans to make use of the funding to speed up U.S. business of its DEXTER soft-tissue surgical robotic, in addition to to help ongoing medical and product-development initiatives.
Distalmotion added that it’s specializing in the U.S. ambulatory surgical procedure heart (ASC) market, which is without doubt one of the fastest-growing segments in surgical care due to the shift towards environment friendly outpatient surgical procedure.
“This funding marks one other vital milestone on our journey,” acknowledged Greg Roche, CEO of Distalmotion. “The continued dedication of our buyers validates our imaginative and prescient to interrupt down boundaries to robotic entry by way of simplified operations.”
“As we enter our subsequent part of U.S. market acceleration, ASCs signify an incredible alternative for DEXTER,” he stated. “The continuing help from our buyers reaffirms our roadmap, our mission, and the worth DEXTER brings to minimally invasive surgical procedure.”
Spun out of the Robotics Lab on the Swiss Federal Institute of Expertise in Lausanne (EPFL) in 2012, Distalmotion stated it’s working to extend the variety of sufferers who can profit from best-in-class minimally invasive care. The Epalinges, Switzerland-based firm has a U.S. workplace in Cleveland.
DEXTER retains surgeons close to sufferers
DEXTER is designed to carry wristed surgical robotics to working rooms (ORs) of any dimension with out modifications, in line with Distalmotion. The corporate stated the cell system could be simply moved between rooms, rapidly arrange, and seamlessly built-in into present procedures for optimum effectivity.
The system comes with a collection of absolutely wristed, single-use robotic devices that improve dexterity and precision, Distalmotion claimed.
DEXTER’s sterile console helps versatile surgical workflows by positioning the surgeon near the affected person for fast bedside entry, famous the corporate. It additionally permits for simple transitions between laparoscopic and robotic methods and enhanced communication with OR groups.
As well as, DEXTER’s open structure permits compatibility with present and future OR applied sciences, together with visualization methods and superior units, for cost-effective provide chain operations, asserted Distalmotion.
DEXTER is commercially obtainable within the U.S. and Europe. Within the U.S., the Distalmotion Dexter L6 System is meant to be used in laparoscopic inguinal hernia restore, cholecystectomy, and whole benign hysterectomy together with salpingo-oophorectomy. The system is indicated for grownup use, outlined as 22 years outdated and older.
In Europe, the Dexter L6 System is meant to help within the correct management of robotic devices throughout urologic laparoscopic surgical procedures, common laparoscopic surgical procedures, and gynecologic laparoscopic surgical procedures. The system is indicated for grownup use, stated the firm.
DEXTER is meant for use on soft-tissue procedures in any OR. Supply: Distalmotion
Distalmotion declares board chair
Distalmotion additionally named Chas McKhann as govt chairman of its board of administrators. With greater than 25 years within the MedTech and life sciences industries, McKhann has expertise in scaling medical machine corporations, business acceleration, and guiding organizations by way of strategic progress.
He beforehand served as CEO of Apollo Endosurgery after which Silk Highway Medical, two publicly traded medical machine corporations, the place he drove gross sales progress that in the end resulted in profitable exits. Distalmotion stated its appointment of McKhann demonstrates its dedication to establishing DEXTER as a number one system in ASCs.
“Distalmotion has reimagined how robotic surgical procedure could be adopted throughout care settings as a result of DEXTER delivers all the advantages of robotic surgical procedure – dexterity, precision, and ergonomics – whereas additionally providing flexibility, effectivity, and worth,” McKhann stated. “With the latest FDA clearance in gynecology and launch of DEXTER product enhancements, the corporate is poised to speed up adoption within the U.S. and globally at this pivotal stage in its progress trajectory.”
Revival Healthcare Capital led Distalmotion’s Collection G spherical, with participation from inside buyers. DEXTER has already been built-in into medical practices throughout Europe and the U.S., with virtually 3,000 sufferers handled, famous Distalmotion.
